135 related articles for article (PubMed ID: 36208584)
1. Capecitabine related neurotoxicity: Clinical and radiologic features.
Ong CS; Gao JL; Tan YJ
J Neurol Sci; 2022 Nov; 442():120444. PubMed ID: 36208584
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine.
Perrain V; Bihan K; Bompaire F; Houillier C; Jomier F; Leclercq D; Combret S; Mahé J; Ricard D; Berzero G; Psimaras D
Eur J Neurol; 2021 Jul; 28(7):2396-2402. PubMed ID: 33817933
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine: toxic encephalopathy.
Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688902
[No Abstract] [Full Text] [Related]
4. Capecitabine-induced acute toxic leukoencephalopathy.
Obadia M; Leclercq D; Wasserman J; Galanaud D; Dormont D; Sahli-Amor M; Psimaras D; Pyatigorskaya N; Law-Ye B
Neurotoxicology; 2017 Sep; 62():1-5. PubMed ID: 28487252
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine-induced Leukoencephalopathy.
Yoshimura K; Tokunaga S; Daga H; Inoue M
Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
[No Abstract] [Full Text] [Related]
6. Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts.
Tan MB; McAdory LE
J Radiol Case Rep; 2016 Mar; 10(3):1-10. PubMed ID: 27200161
[TBL] [Abstract][Full Text] [Related]
7. Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy.
Nicoletti T; Spagni G; Luigetti M; Iorio R
Neurology; 2019 Feb; 92(9):e1000-e1001. PubMed ID: 30804069
[No Abstract] [Full Text] [Related]
8. Permanent lesion to the corticospinal tract after therapy with capecitabine.
Wagner-Altendorf TA; Heldmann M; Hanssen H; Münte TF
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31537598
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine leukoencephalopathy.
Yasiry Z; Obeda MS; Batty R; Sharrack B
Pract Neurol; 2019 Jun; 19(3):270-271. PubMed ID: 30612099
[No Abstract] [Full Text] [Related]
10. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
[TBL] [Abstract][Full Text] [Related]
11. Reversible Toxic Encephalopathy Involving the Cerebellum and Subcortical White Matter Attributed to Capecitabine.
Li Y; Wu X; Zhong W; Tang X
Am J Med Sci; 2022 Apr; 363(4):364-370. PubMed ID: 35114182
[TBL] [Abstract][Full Text] [Related]
12. Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.
Fantini M; Gianni L; Tassinari D; Nicoletti S; Possenti C; Drudi F; Sintini M; Bagli L; Tamburini E; Ravaioli A
J Oncol Pharm Pract; 2011 Sep; 17(3):288-91. PubMed ID: 20926454
[TBL] [Abstract][Full Text] [Related]
13. Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.
Godinho J; Casa-Nova M; Mesquita T; Baptista MJ; Araújo F; Vale J; Passos Coelho JL
J Oncol Pharm Pract; 2019 Mar; 25(2):497-501. PubMed ID: 29121830
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine-induced cerebellar toxicity and TYMS pharmacogenetics.
Saif MW
Anticancer Drugs; 2019 Apr; 30(4):431-434. PubMed ID: 30875351
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
17. Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
Tipples K; Kolluri RB; Raouf S
J Oncol Pharm Pract; 2009 Dec; 15(4):237-9. PubMed ID: 19276137
[TBL] [Abstract][Full Text] [Related]
18. Toxic encephalopathy induced by capecitabine.
Niemann B; Rochlitz C; Herrmann R; Pless M
Oncology; 2004; 66(4):331-5. PubMed ID: 15218302
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature.
Liu L; Brown EN; Abu-Shahin FI
J Oncol Pharm Pract; 2022 Apr; 28(3):703-709. PubMed ID: 34791927
[TBL] [Abstract][Full Text] [Related]
20. Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine.
Monti M; Barone D; Amadori E; Bartolini G; Ruscelli S; Frassineti GL
J Oncol Pharm Pract; 2020 Oct; 26(7):1795-1801. PubMed ID: 32312144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
